<産業資料/調査レポートの題名> 2022年7月17日

世界の等温核酸増幅技術/INAAT市場:製品別(アッセイ&キット、システム)、用途別(感染症[HIV、インフルエンザ]、血液スクリーニング)、種類別(LAMP、SDA、NASBA、HDA)、エンドユーザー別、地域別


◆英文タイトル:Isothermal Nucleic Acid Amplification Technology/INAAT Market by Product (Assay & Kit, System), Application (Infectious disease [HIV, Influenza], Blood Screening), Type (LAMP, SDA, NASBA, HDA), End User, Region - Global Forecast to 2024

1 Introduction (Page No. – 13)
1.1 Objectives of the Study
1.2 Market Definition
1.2.1 Inclusions and Exclusions
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders
2 Research Methodology (Page No. – 18)
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Secondary Sources
2.1.2 Primary Data
2.2 Market Estimation Methodology
2.2.1 Disease-Based Market Estimation Approach
2.2.2 MnM-Know Approach
2.2.3 Application-Based Market Estimation Approach
2.2.4 Primary Research Validation
2.3 Data Triangulation
2.4 Research Assumptions
3 Executive Summary (Page No. – 26)
4 Premium Insights (Page No. – 31)
4.1 Isothermal Nucleic Acid Amplification Technology Market Overview
4.2 North America: Isothermal Nucleic Acid Amplification Technology Market Share, By Product & Country (2019)
4.3 Isothermal Nucleic Acid Amplification Technology Market, By End User
4.4 Isothermal Nucleic Acid Amplification Technology Market, By Application
4.5 Isothermal Nucleic Acid Amplification Technology Market, By Type
5 Market Overview (Page No. – 35)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Rising Prevalence of Infectious Diseases and the Introduction of Newer Pathogens
5.2.1.2 Need for Prompt Diagnosis and Rapid Treatment
5.2.1.3 Increasing Blood Transfusion and Donations
5.2.1.4 Cost-Benefits
5.2.2 Restraint
5.2.2.1 Dominance of Pcr
5.2.3 Opportunities
5.2.3.1 Technology Optimization and Development
5.2.3.2 Emerging Economies
6 Isothermal Nucleic Acid Amplification Technology Market, By Product (Page No. – 39)
6.1 Introduction
6.2 Assays, Kits, and Reagents
6.2.1 Assays, Kits, & Reagents Accounted for the Largest Share of the Market in 2018
6.3 Systems
6.3.1 Market for Systems to Witness Steady Growth Due to Moderate Requirement in Hospitals and Clinical Laboratories
7 Isothermal Nucleic Acid Amplification Technology Market, By Type (Page No. – 44)
7.1 Introduction
7.2 Transcription-Mediated Amplification
7.2.1 Tma Accounts for the Largest Share of the Market
7.3 Loop-Mediated Isothermal Amplification
7.3.1 Rapidity, Stability, and Sensitivity Have Driven the Use of Lamp
7.4 Strand Displacement Amplification
7.4.1 Mirna Amplification for Cancer Diagnosis is the Major Application of Sda
7.5 Helicase-Dependent Amplification
7.5.1 Compatibility With Microfluidic Technologies & Development of Lab-On-Chip Devices Support Market Growth in Hda
7.6 Nucleic Acid Sequence-Based Amplification
7.6.1 Advantages of Nasba Over Pcr has Enhanced Its Adoption in Clinical Settings
7.7 Other Technologies
8 Isothermal Nucleic Acid Amplification Technology Market, By Application (Page No. – 54)
8.1 Introduction
8.2 Infectious Disease Diagnosis
8.2.1 Hepatitis
8.2.1.1 Need to Combat the High Prevalence of Hepatitis has Raised the Demand for INAAT Assays
8.2.2 Ct/Ng
8.2.2.1 Adoption of INAAT for Ct/Ng Diagnosis is Growing Owing to Its Advantages Over Traditional Diagnostic Techniques
8.2.3 Hiv
8.2.3.1 New Product Development Will Provide Considerable Potential for Growth in the Near Future
8.2.4 Influenza
8.2.4.1 Nasba, Lamp, and Samba are Considered Highly Efficient and Reliable Methods of Influenza Diagnosis
8.2.5 Other Infectious Diseases
8.3 Blood Screening
8.3.1 Increasing Number of Blood Donations and Transfusions Have Driven the Use of INAAT in Blood Screening Applications
8.4 Other Applications
9 Isothermal Nucleic Acid Amplification Technology Market, By End User (Page No. – 67)
9.1 Introduction
9.2 Hospitals
9.2.1 Hospitals Formed the Largest End-User Segment in the INAAT Market in 2018
9.3 Reference Laboratories
9.3.1 Outsourcing of Tests From Small Hospitals, Physicians’ Offices, and Clinics to Support the Growth of This End-User Segment
9.4 Academic & Research Institutes
9.4.1 Industry-Academia Collaborations Supporting the Adoption of INAAT
9.5 Other End Users
10 Isothermal Nucleic Acid Amplification Technology Market, By Region (Page No. – 74)
10.1 Introduction
10.2 North America
10.2.1 US
10.2.1.1 US is A Well-Developed Market for Genome Analysis Techniques
10.2.2 Canada
10.2.2.1 Investments for Genomic Research and Development of Diagnostics are Supporting Market Growth in Canada
10.3 Europe
10.3.1 Germany
10.3.1.1 Germany Dominated the European INAAT Market in 2018
10.3.2 France
10.3.2.1 Supportive Government Policies That Aim to Ease Public Access to Diagnostic Assay Procedures to Drive Growth in the INAAT Market
10.3.3 UK
10.3.3.1 Adoption of INAAT Products is Expected to Increase in the UK as A Result of the Growing Focus of Public and Private Organizations on Genomics Research
10.3.4 RoE
10.4 Asia Pacific
10.4.1 Asia Pacific to Offer Significant Growth Opportunities for INAAT Market Players
10.5 RoW
10.5.1 The RoW INAAT Market is Significantly Smaller Than Other Markets
11 Competitive Landscape (Page No. – 99)
11.1 Introduction
11.2 Market Ranking Analysis, 2018
11.3 Competitive Leadership Mapping
11.3.1 Visionary Leaders
11.3.2 Innovators
11.3.3 Dynamic Differentiators
11.3.4 Emerging Companies
11.4 Competitive Scenario
11.4.1 Key Product Launches
11.4.2 Key Acquisitions
11.4.3 Key Partnerships, Agreements, Contracts, and Collaborations
11.4.4 Key Expansions
12 Company Profiles (Page No. – 103)
12.1 Grifols, S.A.
12.1.1 Business Overview
12.1.2 Products Offered
12.1.3 Recent Developments
12.1.4 MnM View
12.2 Hologic, Inc.
12.2.1 Business Overview
12.2.2 Products Offered
12.2.3 Recent Developments
12.2.4 MnM View
12.3 Abbott Laboratories, Inc.
12.3.1 Business Overview
12.3.2 Products Offered
12.3.3 Recent Developments
12.3.4 MnM View
12.4 Becton, Dickinson and Company
12.4.1 Business Overview
12.4.2 Products Offered
12.5 Meridian Bioscience
12.5.1 Business Overview
12.5.2 Products Offered
12.5.3 Recent Developments
12.6 EIKEN CHEMICALS Co., Ltd.
12.6.1 Business Overview
12.6.2 Products Offered
12.6.3 Recent Developments
12.7 Quidel Corporation
12.7.1 Business Overview
12.7.2 Products Offered
12.7.3 Recent Developments
12.8 Tecan Trading AG
12.8.1 Business Overview
12.8.2 Products Offered
12.8.3 Recent Developments
12.9 Diasorin Group S.P.A
12.9.1 Business Overview
12.9.2 Products Offered
12.10 Qiagen
12.10.1 Business Overview
12.10.2 Products Offered
12.11 Illumina, Inc.
12.11.1 Business Overview
12.11.2 Products Offered
12.12 Thermo Fisher Scientific, Inc.
12.12.1 Business Overview
12.12.2 Products Offered
12.13 Biomérieux SA
12.13.1 Business Overview
12.13.2 Products Offered
12.14 GE Healthcare
12.14.1 Business Overview
12.14.2 Products Offered
12.15 Other Companies
12.15.1 New England Biolabs, Inc.
12.15.2 Lucigen Corporation
12.15.3 Ustar Biotechnologies Ltd.
12.15.4 TwistDx Limited
12.15.5 Mast Group Ltd.
12.15.6 Genomtec SA
13 Appendix (Page No. – 134)
13.1 Discussion Guide
13.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
13.3 Available Customizations
13.4 Related Reports
13.5 Author Details


LINEで送る
Share on LinkedIn
このエントリーをはてなブックマークに追加
Bookmark this on BuzzURL
Bookmark this on Yahoo Bookmark